Pesquisar
Schrodinger Inc
SDGRAdicionar à lista de desejos
19.020USD
+0.220+1.17%
Fechamento 09-11 16:00（ET）
1.42BValor de mercado
PerdaP/L TTM
Mais detalhes de Schrodinger Inc Empresa
Schrodinger, Inc. operates a physics-based computational platform that enables the discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Its segments include Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in the material science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The Company's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor), and others. Its software has been used by researchers around the world at more than 1,818 academic institutions.
Schrodinger Inc Perfil
Código da empresaSDGR
Nome da EmpresaSchrodinger Inc
Data de listagemFeb 06, 2020
CEOFarid (Ramy Farid)
Número de funcionários891
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 06
Endereço1540 Broadway
CidadeNEW YORK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal10036
Telefone15032991150
Sitehttps://www.schrodinger.com
Código da empresaSDGR
Data de listagemFeb 06, 2020
CEOFarid (Ramy Farid)
Executivos da empresa Schrodinger Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Richard A. Friesner, Ph.D.
Dr. Richard A. Friesner, Ph.D.
Director
Director
1.41M
+0.58%
Mr. Kenneth Patrick Lorton
Mr. Kenneth Patrick Lorton
Executive Vice President and Chief Operating Officer - Software
Executive Vice President and Chief Operating Officer - Software
72.66K
+50.36%
Ms. Margaret Dugan, M.D.
Ms. Margaret Dugan, M.D.
Chief Medical Officer
Chief Medical Officer
24.57K
-5.68%
Dr. Rosana Kapeller-Libermann, M.D., Ph.D.
Dr. Rosana Kapeller-Libermann, M.D., Ph.D.
Independent Director
Independent Director
19.39K
+41.98%
Mr. Arun Oberoi
Mr. Arun Oberoi
Independent Director
Independent Director
19.39K
+41.98%
Ms. Yvonne Tran, J.D.
Ms. Yvonne Tran, J.D.
Chief People Officer, Executive Vice President and Chief Legal Officer
Chief People Officer, Executive Vice President and Chief Legal Officer
10.49K
-402.13%
Dr. Ramy Farid, Ph.D.
Dr. Ramy Farid, Ph.D.
President and Chief Executive Officer, Director
President and Chief Executive Officer, Director
--
--
Dr. Robert Abel, Ph.D.
Dr. Robert Abel, Ph.D.
Executive Vice President and Chief Scientific Officer - Platform
Executive Vice President and Chief Scientific Officer - Platform
--
--
Dr. Karen Akinsanya, Ph.D.
Dr. Karen Akinsanya, Ph.D.
President, Head - Therapeutics R&D and Chief Strategy Officer - Partnerships
President, Head - Therapeutics R&D and Chief Strategy Officer - Partnerships
--
--
Mr. Michael Lynton
Mr. Michael Lynton
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Richard A. Friesner, Ph.D.
Dr. Richard A. Friesner, Ph.D.
Director
Director
1.41M
+0.58%
Mr. Kenneth Patrick Lorton
Mr. Kenneth Patrick Lorton
Executive Vice President and Chief Operating Officer - Software
Executive Vice President and Chief Operating Officer - Software
72.66K
+50.36%
Ms. Margaret Dugan, M.D.
Ms. Margaret Dugan, M.D.
Chief Medical Officer
Chief Medical Officer
24.57K
-5.68%
Dr. Rosana Kapeller-Libermann, M.D., Ph.D.
Dr. Rosana Kapeller-Libermann, M.D., Ph.D.
Independent Director
Independent Director
19.39K
+41.98%
Mr. Arun Oberoi
Mr. Arun Oberoi
Independent Director
Independent Director
19.39K
+41.98%
Ms. Yvonne Tran, J.D.
Ms. Yvonne Tran, J.D.
Chief People Officer, Executive Vice President and Chief Legal Officer
Chief People Officer, Executive Vice President and Chief Legal Officer
10.49K
-402.13%
Perguntas frequentes
Quem são os cinco principais acionistas de Schrodinger Inc?
Os cinco principais acionistas de Schrodinger Inc são: Dr. Richard A. Friesner, Ph.D.
Quantas instituições possuem ações da Schrodinger Inc (SDGR)?
Em 2026Q1, 525 instituições possuíam ações da Schrodinger Inc, com valor de mercado aproximado de 71.93M, representando 109.89% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -7222611.00.